For patients previously unresponsive to bladder cancer treatment, UC San Diego Health offers a new gene therapy that’s changing the way patients and doctors manage the disease.
UC San Diego Health is the first to offer a non-invasive gene therapy treatment for patients with localized bladder cancer. The novel therapy “represents a significant milestone for bladder cancer treatment” and offers another pathway to disease management that was previously unavailable, “until now,” says urologic oncologist at UC San Diego Health, Dr. Aditya Bagrodia.
